Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Nuvectis Pharma, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Jul-27-20
Revenues2.40.89.50.0
            Revenue growth215.2%-91.9%  
Cost of goods sold1.80.419.10.0
Gross profit0.70.4-9.50.0
            Gross margin28.1%46.6%-100.0% 
Research and development13.29.5  
General and administrative6.73.73.30.0
EBIT-19.2-12.9-12.90.0
            EBIT margin-787.3%-1663.7%-135.1% 
Pre-tax income-19.1-12.9-12.90.0
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-19.1-12.9-12.90.0
            Net margin-781.2%-1663.2%-135.0% 
 
Diluted EPS($1.51)($3.02)$0.00$0.00
Shares outstanding (diluted)12.74.34,268.33,900.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy